Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas.
Sign Up to like & getrecommendations! Published in 2022 at "Journal francais d'ophtalmologie"
DOI: 10.1016/j.jfo.2022.01.002
Abstract: PURPOSE To evaluate effect of first-line dopamine agonist (DA) therapy as an alternative to surgery for visual field defect (VFD) recovery in giant and macro-prolactinoma. METHODS In this retrospective study, 125 patients with giant and… read more here.
Keywords: dopamine agonist; giant macro; macro prolactinomas; visual field ... See more keywords
Resolution of dopamine agonist-resistant hyperprolactinemia by hysterectomy: a case report
Sign Up to like & getrecommendations! Published in 2018 at "Gynecological Endocrinology"
DOI: 10.1080/09513590.2017.1379501
Abstract: Abstract Prolactin-producing uterine leiomyomas are very rare. Although hyperprolactinemia rapidly improves after removal of such leiomyomas, no preoperative diagnostic test has been established for prolactin-producing uterine leiomyomas. A 45-year-old Japanese woman, gravida 3 para 3,… read more here.
Keywords: prolactin producing; dopamine agonist; hyperprolactinemia; producing uterine ... See more keywords
Combination of dopamine agonist and prostaglandin administration for pregnancy termination in bitches – a novel approach
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Applied Animal Research"
DOI: 10.1080/09712119.2020.1814784
Abstract: ABSTRACT Pregnancy termination is a required procedure in companion animal practice. In healthy bitches with confirmed pregnancy, good results are obtained with the combination of prostaglandin F2 and dopamine agonist, followed by regular sonographic examination… read more here.
Keywords: combination; pregnancy; pregnancy termination; dopamine agonist ... See more keywords
Macroprolactinoma-Induced Syndrome of Inappropriate Antidiuresis and Its Reversal with Dopamine Agonist Therapy.
Sign Up to like & getrecommendations! Published in 2022 at "Laboratory medicine"
DOI: 10.1093/labmed/lmac025
Abstract: Hyponatremia is an uncommon manifestation of pituitary adenomas. Herein, I report a case of syndrome of inappropriate antidiuresis (SIAD) caused by a macroprolactinoma that rapidly resolved with dopamine agonist therapy. A 29-year-old White woman presented… read more here.
Keywords: syndrome inappropriate; agonist therapy; dopamine agonist; macroprolactinoma ... See more keywords
Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Endocrinology"
DOI: 10.1111/cen.14714
Abstract: To estimate the proportion of patients with persistent normoprolactinaemia following dopamine agonist (DA) withdrawal and to identify predictors of successful withdrawal in patients with hyperprolactinaemia. read more here.
Keywords: treatment patients; withdrawal; dopamine agonist; agonist treatment ... See more keywords
Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors
Sign Up to like & getrecommendations! Published in 2021 at "Parkinson's Disease"
DOI: 10.1155/2021/9952743
Abstract: Objective To investigate the use of dopamine agonists and monoamine oxidase type B (MAO-B) inhibitors in the Norwegian population, between 1 July 2006 and 31 December 2016. Our primary endpoint was time until need for… read more here.
Keywords: mao inhibitor; dopamine agonists; mao inhibitors; dopamine agonist ... See more keywords
Cariprazine: A new partial dopamine agonist with a familiar profile
Sign Up to like & getrecommendations! Published in 2022 at "Australasian Psychiatry"
DOI: 10.1177/10398562211064254
Abstract: Objective Cariprazine is the third partial dopamine agonist now available in Australia. This paper will review the properties, evidence and likely clinical place of cariprazine. Conclusion Cariprazine is a partial agonist with high affinity at… read more here.
Keywords: dopamine; cariprazine; partial dopamine; dopamine agonist ... See more keywords
Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Medical Case Reports"
DOI: 10.1186/s13256-018-1939-x
Abstract: BackgroundDopamine agonists are the standard first-line medical therapy for prolactinoma. We report a rare case of giant prolactinoma with a first epileptic seizure due to rapid reduction of the tumor as a complication of dopamine… read more here.
Keywords: agonist therapy; case; prolactinoma; therapy ... See more keywords
Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas.
Sign Up to like & getrecommendations! Published in 2019 at "European journal of endocrinology"
DOI: 10.1530/eje-18-0682
Abstract: Background Dopamine agonists (DAs) are the main treatment for patients with hyperprolactinemia and prolactinomas. Recently, an increasing number of reports emphasized DAs' psychological side effects, either de novo or as exacerbations of prior psychiatric disease.… read more here.
Keywords: psychological effects; effects dopamine; patients hyperprolactinemia; dopamine agonist ... See more keywords
Pulmonary Artery Occlusion and Mediastinal Fibrosis in a Patient on Dopamine Agonist Treatment for Hyperprolactinemia
Sign Up to like & getrecommendations! Published in 2017 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2017.00492
Abstract: Unusual forms of pulmonary hypertension include pulmonary hypertension related to mediastinal fibrosis and the use of serotonergic drugs. Here, we describe a patient with diffuse mediastinal fibrosis and pulmonary hypertension while she was on dopamine… read more here.
Keywords: pulmonary hypertension; fibrosis; mediastinal fibrosis; pulmonary artery ... See more keywords